t(11;18)-bearing pulmonary mucosa-associated lymphoid tissue lymphoma responding to cladribine

International Journal of Hematology

Volumn 80, Issue 1, 2004, Pages 70-74

  Kusumoto, Shigeru ^a   Kobayashi, Yukio ^a   Tanimoto, Tetsuya E ^a   Hasegawa, Tatsuro ^a   Yokota, Yukiko ^a   Tanimoto, Kazuki ^a   Sekiguchi, Naohiro ^a   Narabayashi, Masaru ^a   Watanabe, Takashi ^a   Matsuno, Yoshihiro ^a   Tobinai, Kensei ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cladribine; Leukemic transformation; Lung; MALT lymphoma; t(11; 18)

Indexed keywords

CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GLUCOCORTICOID; PREDNISOLONE; VINCRISTINE SULFATE;

ADULT; API2 GENE; API2 MLT FUSION GENE; ARTICLE; B CELL LYMPHOMA; CANCER INVASION; CASE REPORT; CHROMOSOME TRANSLOCATION 1; CLINICAL FEATURE; DISEASE COURSE; DRUG RESPONSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LYMPHOMA CELL; MALT1 GENE; MLT1 GENE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

ADULT; ANTINEOPLASTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 18; CLADRIBINE; FEMALE; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; RESPIRATORY MUCOSA; TOMOGRAPHY, X-RAY COMPUTED; TRANSLOCATION, GENETIC;

EID: 3142769773     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.03170     Document Type: Article

References (19)

1. Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
2. Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol. 1997;15:1624-1630.
3. Isaacson PG. The MALT lymphoma concept updated. Ann Oncol. 1995;6:319-320.
4. Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 2000;95:802-806.
5. Auer IA, Gascoyne RD, Connors JM, et al. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol. 1997;8:979-985.
6. Ott G, Katzenberger T, Greiner A, et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res. 1997;57:3944-3948.
7. Dyer MJS. The pathogenetic role of oncogenes deregulated by chromosomal translocation in B-cell malignancies. Int J Hematol. 2003;77:315-320.
8. Kobayashi Y, Nakata M, Maekawa M, et al. Detection of t(11;18) in MALT-type lymphoma with dual-color fluorescence in situ hybridization and reverse transcriptase-polymerase chain reaction analysis. Diagn Mol Pathol. 2001;10:207-213.
9. Saven A, Emanuele S, Kosty M, Koziol J, Ellison D, Piro L. 2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphoma. Blood. 1995;86:1710-1716.
10. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;21) associated with mucosa-associated lymphoid tissue lymphomas. Blood. 1999;93:3601-3609.
11. Ye H, Liu H, Attygalle A, et al. Variable frequencies of t(11;18) (q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood. 2003;102:1010-1028.
12. Okabe M, Inagaki H, Oshima K, et al. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Pathol. 2003;162:1113-1322.
13. Zinzani PL, Magagnoli M, Galieni P, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol. 1999;17:1254-1258.
14. Zucca E, Roggero E, Pileri S. B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low-grade gastric tumours. Br J Haematol. 1998;100:3-14.
15. Zucca M, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003;101:2489-2495.
16. Asatiani E, Cohen P, Ozdemirli M, et al. Monoclonal gammopathy in extranodal subtypes of marginal zone lymphoma (ENMZL) correlates with advanced disease with involvement of bone marrow [abstract]. Blood. 2003;102. Abstract 2337.
17. Conconi A, Martinelli G, Thieblemont A, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood. 2003;102:2741-2745.
18. Jaeger G, Neumeister P, Bezinschek R, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol. 2002;20:3872-3877.
19. Tobinai K, Kobayashi Y, Morishima Y, et al. Prolonged cytopenia and myelodysplastic syndrome after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphoma: results of Japanese phase II study [abstract]. Proc Am Soc Clin Oncol. 2001;20:228b. Abstract 2664.